Reading Time: 3 minutes Melodiol Global Health Limited (ASX:ME1) (‘Melodiol’ or ‘the Company’), is pleased to announce a non-binding
Reading Time: 2 minutes Melodiol Global Health Limited (ASX:ME1) (‘Melodiol’ or ‘the Company’) is pleased to advise that it
Reading Time: 5 minutes Overview The global regulatory climate around cannabis use is evolving and has resulted in a
Reading Time: 8 minutes Business highlights COMP360 psilocybin treatment in treatment-resistant depression (TRD): Phase 3 program ongoing, composed of
Reading Time: 6 minutes “These results, with early and lasting improvement in symptoms following a single administration of COMP360,
Reading Time: 6 minutes “These results, with early and lasting improvement in symptoms following a single administration of COMP360,
Reading Time: 6 minutes “These results, with early and lasting improvement in symptoms following a single administration of COMP360,
Reading Time: 7 minutes FinancialBuzz.com News Commentary The cannabis market in the United States has experienced significant growth in
Reading Time: 2 minutes Subordinate voting shares expected to begin trading under new ticker symbols on July 8, 2024
Reading Time: 2 minutes Melodiol Global Health Limited (ASX:ME1) (‘Melodiol’ or ‘the Company’) is pleased to advise that it